Literature DB >> 15056413

[Inflammatory bowel disease and amyloidosis].

M Iñarrairaegui Bastarrica1, A Arín Letamendia, J M Zozaya Urmeneta, C Rodríguez Gutiérrez, B Castán Martínez, I Amat Villegas, R Beloqui Pérez.   

Abstract

Secondary (AA) amyloidosis is a rare but serious complication of longstanding inflammatory bowel disease that can affect the patient's prognosis more than the underlying disease. Although early diagnosis of this complication is becoming more frequent, its effective treatment continues to pose a challenge to the clinician. We present two cases of Crohn's disease complicated by secondary amyloidosis after two years, and describe their outcome.

Entities:  

Mesh:

Year:  2004        PMID: 15056413     DOI: 10.1016/s0210-5705(03)70456-7

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  1 in total

1.  Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor.

Authors:  M M Boscá; C M Pérez-Baylach; M A Solis; R Antón; E Mayordomo; S Pons; M Mínguez; A Benages
Journal:  Gut       Date:  2006-02       Impact factor: 23.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.